5:12 PM
 | 
Feb 17, 2010
 |  BC Extra  |  Company News

BG Medicine, Merck in biomarker deal

Merck & Co. Inc. (NYSE:MRK) partnered with BG Medicine Inc. (Waltham, Mass.) to develop and validate an...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >